A Systemic Screening for TB Disease in High-risk Groups in Barcelona
NCT ID: NCT06706596
Last Updated: 2024-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2022-07-22
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Will attend a small talk/lecture about Tuberculosis (TB) disease
2. Will be interviewed and screened for the presence of TB symptoms: cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks
3. Individuals screened positive for TB will be referred to the hospital for further testing (Chest X-ray, visit, lab tests)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vulnerable populations residing in the Barcelona metropolitan area with a high risk of developing TB
Individuals from vulnerable populations residing in the Barcelona metropolitan area who are at high risk of developing tuberculosis (i.e. war refugees, migrants, individuals living in socio-deprived neighborhoods)
Screening for TB symptoms
Individuals will be screened for cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks
Chest X-ray
Chest X-ray will be performed to diagnose or exclude TB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Screening for TB symptoms
Individuals will be screened for cough, blood in sputum, fever, weight loss, night sweats and chills lasting for \>2 weeks
Chest X-ray
Chest X-ray will be performed to diagnose or exclude TB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catalan Public Health Agency
UNKNOWN
Consorci Sanitari de Barcelona (CSB)
UNKNOWN
SMA-TB Consortium
UNKNOWN
INNOVA4TB Consortium
UNKNOWN
Fundació Lluita contra les Infeccions
UNKNOWN
Hospital Vall d'Hebron -Unitat de Drassanes
UNKNOWN
ADVANCE-TB Consortium
UNKNOWN
Germans Trias i Pujol Hospital
OTHER
Fundació Institut Germans Trias i Pujol
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cris Vilaplana
Head of Tuberculosis Investigational Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cristina Vilaplana, MD, PhD
Role: STUDY_CHAIR
Fundació i Hospital Germans Trias i Pujol (IGTP-HUGTIP)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IGTP
Badalona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYS-TB-S
Identifier Type: -
Identifier Source: org_study_id